Bio Key International Stock Analysis
BKYI Stock | USD 0.92 0.04 4.55% |
BIO Key International is undervalued with Real Value of 1.18 and Target Price of 2.0. The main objective of BIO Key stock analysis is to determine its intrinsic value, which is an estimate of what BIO Key International is worth, separate from its market price. There are two main types of BIO Key's stock analysis: fundamental analysis and technical analysis.
The BIO Key stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BIO Key's ongoing operational relationships across important fundamental and technical indicators.
BIO |
BIO Stock Analysis Notes
The company recorded a loss per share of 8.66. BIO Key International last dividend was issued on the 20th of November 2020. The entity had 1:18 split on the 21st of December 2023. BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey. Bio-Key Intl operates under Security Protection Services classification in the United States and is traded on NASDAQ Exchange. It employs 51 people. For more info on BIO Key International please contact Michael DePasquale at 732 359 1100 or go to https://www.bio-key.com.BIO Key International Investment Alerts
BIO Key is way too risky over 90 days horizon | |
BIO Key has some characteristics of a very speculative penny stock | |
BIO Key appears to be risky and price may revert if volatility continues | |
BIO Key has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 7.75 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 3.44 M. | |
BIO Key International currently holds about 4.89 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
BIO Key has a poor financial position based on the latest SEC disclosures | |
Latest headline from gurufocus.com: ARMISTICE CAPITAL, LLC Acquires New Stake in BIO-key International Inc |
BIO Key International Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to BIO Key previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
29th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
BIO Largest EPS Surprises
Earnings surprises can significantly impact BIO Key's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2021-11-15 | 2021-09-30 | -0.11 | -0.13 | -0.02 | 18 | ||
2021-03-25 | 2020-12-31 | -0.16 | -0.18 | -0.02 | 12 | ||
2021-08-16 | 2021-06-30 | -0.11 | -0.15 | -0.04 | 36 |
BIO Stock Institutional Investors
Shares | Abich Financial Wealth Management Llc | 2024-09-30 | 0.0 | Group One Trading, Lp | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 250 K | Tower Research Capital Llc | 2024-06-30 | 5.9 K | Ubs Group Ag | 2024-06-30 | 2.4 K | Advisor Group Holdings, Inc. | 2024-06-30 | 262 | Jpmorgan Chase & Co | 2024-06-30 | 71.0 | Headlands Technologies Llc | 2024-09-30 | 16.0 | Bank Of America Corp | 2024-06-30 | 14.0 | Harbour Investments, Inc. | 2024-09-30 | 6.0 |
BIO Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M.BIO Profitablity
The company has Profit Margin (PM) of (0.92) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.45.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (2.74) | (2.88) | |
Return On Capital Employed | (6.77) | (6.43) | |
Return On Assets | (1.89) | (1.98) | |
Return On Equity | (8.01) | (7.61) |
Management Efficiency
BIO Key International has return on total asset (ROA) of (0.5568) % which means that it has lost $0.5568 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5811) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -2.88. The BIO Key's current Return On Capital Employed is estimated to increase to -6.43. As of now, BIO Key's Intangibles To Total Assets are decreasing as compared to previous years. The BIO Key's current Fixed Asset Turnover is estimated to increase to 31.17, while Total Assets are projected to decrease to under 4.3 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 1.90 | 1.99 | |
Tangible Book Value Per Share | (0.61) | (0.65) | |
Enterprise Value Over EBITDA | (0.20) | (0.19) | |
Price Book Value Ratio | 1.58 | 1.66 | |
Enterprise Value Multiple | (0.20) | (0.19) | |
Price Fair Value | 1.58 | 1.66 | |
Enterprise Value | 5 M | 4.7 M |
The strategic vision of BIO Key International management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Operating Margin (1.45) | Profit Margin (0.92) | Beta 0.245 | Return On Assets (0.56) | Return On Equity (4.58) |
Technical Drivers
As of the 26th of November, BIO Key shows the risk adjusted performance of 0.0314, and Mean Deviation of 8.38. BIO Key International technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BIO Key International Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BIO Key middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BIO Key International. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BIO Key International Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO Key insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO Key's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BIO Key insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BIO Key Outstanding Bonds
BIO Key issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BIO Key International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BIO bonds can be classified according to their maturity, which is the date when BIO Key International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
BIOGEN INC Corp BondUS09062XAG88 | View | |
BIOGEN INC Corp BondUS09062XAH61 | View | |
BIIB 325 15 FEB 51 Corp BondUS09062XAK90 | View | |
MGM Resorts International Corp BondUS552953CD18 | View |
BIO Key Predictive Daily Indicators
BIO Key intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BIO Key stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BIO Key Forecast Models
BIO Key's time-series forecasting models are one of many BIO Key's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BIO Key's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BIO Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BIO Key prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BIO shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BIO Key. By using and applying BIO Stock analysis, traders can create a robust methodology for identifying BIO entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (1.12) | (1.06) | |
Operating Profit Margin | (1.14) | (1.20) | |
Net Loss | (1.10) | (1.15) | |
Gross Profit Margin | 0.18 | 0.18 |
Current BIO Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BIO analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BIO analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
2.0 | Buy | 1 | Odds |
Most BIO analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BIO stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BIO Key International, talking to its executives and customers, or listening to BIO conference calls.
BIO Stock Analysis Indicators
BIO Key International stock analysis indicators help investors evaluate how BIO Key stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BIO Key shares will generate the highest return on investment. By understating and applying BIO Key stock analysis, traders can identify BIO Key position entry and exit signals to maximize returns.
Begin Period Cash Flow | 2.6 M | |
Long Term Debt | 188.8 K | |
Common Stock Shares Outstanding | 560.3 K | |
Total Stockholder Equity | 1.1 M | |
Tax Provision | 122.4 K | |
Property Plant And Equipment Net | 257.1 K | |
Cash And Short Term Investments | 511.4 K | |
Cash | 511.4 K | |
Accounts Payable | 1.3 M | |
Net Debt | -146.1 K | |
50 Day M A | 1.0362 | |
Total Current Liabilities | 3.2 M | |
Other Operating Expenses | 16.6 M | |
Non Current Assets Total | 1.9 M | |
Non Currrent Assets Other | 229.8 K | |
Stock Based Compensation | 265.7 K |
Complementary Tools for BIO Stock analysis
When running BIO Key's price analysis, check to measure BIO Key's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO Key is operating at the current time. Most of BIO Key's value examination focuses on studying past and present price action to predict the probability of BIO Key's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO Key's price. Additionally, you may evaluate how the addition of BIO Key to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |